Theravance Biopharma (TBPH) Shares Issued (2016 - 2025)
Historic Shares Issued for Theravance Biopharma (TBPH) over the last 13 years, with Q3 2025 value amounting to $258000.0.
- Theravance Biopharma's Shares Issued changed N/A to $258000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $411000.0, marking a year-over-year decrease of 1543.21%. This contributed to the annual value of $508000.0 for FY2024, which is 1779.94% down from last year.
- According to the latest figures from Q3 2025, Theravance Biopharma's Shares Issued is $258000.0.
- Over the past 5 years, Theravance Biopharma's Shares Issued peaked at $108.2 million during Q2 2021, and registered a low of -$1000.0 during Q3 2023.
- Moreover, its 5-year median value for Shares Issued was $133000.0 (2024), whereas its average is $12.1 million.
- Its Shares Issued has fluctuated over the past 5 years, first plummeted by 20000.0% in 2023, then tumbled by 2312.14% in 2024.
- Quarter analysis of 5 years shows Theravance Biopharma's Shares Issued stood at $108.2 million in 2021, then tumbled by 99.71% to $314000.0 in 2022, then plummeted by 44.9% to $173000.0 in 2023, then dropped by 23.12% to $133000.0 in 2024, then skyrocketed by 93.98% to $258000.0 in 2025.
- Its Shares Issued was $258000.0 in Q3 2025, compared to $20000.0 in Q1 2025 and $133000.0 in Q4 2024.